- THE BLAZE - DANIEL HOROWITZ - OCT 25, 2021 -
Horowitz: UK report raises concerns about suboptimal vaxxine antibodies erasing natural immunity
In many areas of life, half a loaf is better than no loaf at all. But when it comes to vaccines, the opposite is true. Half-baked antibodies injected throughout the entire population can make the virus even stronger and negate people's natural immunity. Thus, all the defenses of the leaky vaccine suggesting that it at least conveys "some" protection are actually extremely concerning, a point driven home by a nugget in the most recent surveillance report from Public Health England (PHE).
On page 23 of PHE's "COVID-19 vaccine surveillance report Week 42," British health officials report a shocking finding. They believe their serology tests are underestimating the number of people with prior infection due to "recent observations from UK Health Security Agency (UKHSA) surveillance data that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination." In other words, the vaccine might be reducing the all-important N antibodies that one generates from natural infection. Kudos to former NYT reporter Alex Berenson for discovering this important point.
Until now, we've been operating under the assumption that those with prior infection don't need the vaccine to boost immunity and taking the shots would only expose them to the growing risk of side effects. However, what if the shots are actually sliding back the natural immunity generated in those with previous infection? What if that is related to the macro concern that a narrow-spectrum vaccine with suboptimal antibodies that only recognize the "S" (spike) protein of the virus but not the "N" (nucleocapsid) of the virus will cause B cells in those with the vaccine to learn to produce only S antibodies, which are slower-acting and less sterilizing (don't stop transmission) than N antibodies, which are faster-acting and are more effective in their protection against the virus?
It's not like we weren't confronted with some other warning signs that the vaccine could perhaps negate some of the immunity acquired from prior infection. In March, researchers from Mount Sinai in New York and Hospital La Paz in Madrid posted a preprint study indicating that at least the second Pfizer shot might weaken T cell immunity. In a shocking discovery after monitoring a group of vaccinated people both with and without prior infection, they found "in individuals with a pre-existing immunity against SARS-CoV-2, the second vaccine dose not only fail to boost humoral immunity but determines a contraction of the spike-specific T cell response." They also note that other research has shown "the second vaccination dose appears to exert a detrimental effect in the overall magnitude of the spike-specific humoral response in COVID-19 recovered individuals."
LEIA MAIS AQUI >
Acesse a minha HOME PAGE, para assistir meus vídeos e ler meus livros: https://www.heitordepaola.online/